Decision-Making under Uncertain Conditions: The Internist, as a Director of the Diagnostic/Therapeutic Pathway in Grey Zones
Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment ofCognitive Impairment in Schizophrenia